As of October 22, 2026, EPN / Euphorinol is illegal to sell at retail in Ohio as edible / ingestible. EPN edible illegal in Ohio - SB 56 excludes cannabinoids synthesized or manufactured outside the plant from 'hemp' (EPN falls to marihuana);. Effective 2026-03-20. Controlling source: Ohio Rev. Code Sec. 928.01 (SB 56, eff. Mar 20, 2026) - synthesized/manufactured-outside-the-plant exclusion + 0.4 mg similar-effects container cap.
Verified October 22, 2026 (hash check) · confidence: confirmed[Hemp does not include any final hemp-derived cannabinoid product containing] Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; ... Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol.
As of October 22, 2026, EPN / Euphorinol is illegal to sell at retail in Ohio as vape / inhalable. EPN vape illegal in Ohio - SB 56 excludes cannabinoids synthesized or manufactured outside the plant from 'hemp' (EPN falls to marihuana); t. Effective 2026-03-20. Controlling source: Ohio Rev. Code Sec. 928.01 (SB 56, eff. Mar 20, 2026) - synthesized/manufactured-outside-the-plant exclusion + 0.4 mg similar-effects container cap.
Verified October 22, 2026 (hash check) · confidence: confirmed[Hemp does not include any final hemp-derived cannabinoid product containing] Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; ... Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol.
| Form | Status | Headline | Verified |
|---|---|---|---|
| Edible / ingestible | Illegal | EPN edible illegal in Ohio - SB 56 excludes cannabinoids synthesized or manufactured outside the plant from 'hemp' (EPN falls to marihuana); | 2026-10-22 |
| Vape / inhalable | Illegal | EPN vape illegal in Ohio - SB 56 excludes cannabinoids synthesized or manufactured outside the plant from 'hemp' (EPN falls to marihuana); t | 2026-10-22 |
Among Ohio's 5 neighbors, Indiana, Kentucky, Michigan and West Virginia are restricted; Pennsylvania is legal.
Map and neighbor comparison show edible / ingestible. Open the interactive map · Every compound in Ohio
Federally restricted. Contested hemp lane now; excluded as semi-synthetic at the Nov 12, 2026 cliff (P.L. 119-37 Sec. 781) Federal detail
4 instruments on file for this compound's framework in Ohio; 2 of 2 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
6c140edf84af933dAs used in this chapter: (A) "Container" means the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton, or cartridge. "Container" does not include bulk shipping containers or outer wrappings that are not essential for the final retail delivery or sale to an end consumer for personal or household use. (C) "Hemp" means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of not more than three-tenths per cent on a dry weight basis. "Hemp" includes industrial hemp. "Hemp" does not include any of the following: (1) Any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of three-tenths per cent in the plant on a dry weight basis; (2) Any intermediate hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) More than three-tenths per cent combined total of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects or are marketed to have similar effects on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (3) Any intermediate hemp-derived cannabinoid product that is marketed or sold as a final product or directly to an end consumer for personal or household use; (4) Any final hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (E) "Hemp-derived cannabinoid product" means any intermediate or final product derived from hemp, other than industrial hemp, that contains cannabinoids in any form and is intended for human or animal use through any means of application or administration, such as inhalation, ingestion, or topical application. "Hemp-derived cannabinoid product" does not include a drug that is the subject of an application approved under subsection (c) or (j) of 21 U.S.C. 355. (H) "Intermediate hemp-derived cannabinoid product" means a hemp-derived cannabinoid product that is either of the following: (1) Not yet in the final form or preparation marketed or intended to be used or consumed by a human or animal; (2) A powder, liquid, tablet, oil, or other product form that is intended or marketed to be mixed, dissolved, formulated, or otherwise added to or prepared with or into any other substance prior to administration or consumption.
6c140edf84af933dAs used in this chapter: (A) "Container" means the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton, or cartridge. "Container" does not include bulk shipping containers or outer wrappings that are not essential for the final retail delivery or sale to an end consumer for personal or household use. (C) "Hemp" means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of not more than three-tenths per cent on a dry weight basis. "Hemp" includes industrial hemp. "Hemp" does not include any of the following: (1) Any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of three-tenths per cent in the plant on a dry weight basis; (2) Any intermediate hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) More than three-tenths per cent combined total of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects or are marketed to have similar effects on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (3) Any intermediate hemp-derived cannabinoid product that is marketed or sold as a final product or directly to an end consumer for personal or household use; (4) Any final hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (E) "Hemp-derived cannabinoid product" means any intermediate or final product derived from hemp, other than industrial hemp, that contains cannabinoids in any form and is intended for human or animal use through any means of application or administration, such as inhalation, ingestion, or topical application. "Hemp-derived cannabinoid product" does not include a drug that is the subject of an application approved under subsection (c) or (j) of 21 U.S.C. 355. (H) "Intermediate hemp-derived cannabinoid product" means a hemp-derived cannabinoid product that is either of the following: (1) Not yet in the final form or preparation marketed or intended to be used or consumed by a human or animal; (2) A powder, liquid, tablet, oil, or other product form that is intended or marketed to be mixed, dissolved, formulated, or otherwise added to or prepared with or into any other substance prior to administration or consumption.
eda464f28d51571e(C) "Hemp" means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of not more than three-tenths per cent on a dry weight basis. "Hemp" includes industrial hemp. "Hemp" does not include any of the following: (1) Any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of three-tenths per cent in the plant on a dry weight basis; (2) Any intermediate hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) More than three-tenths per cent combined total of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects or are marketed to have similar effects on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (3) Any intermediate hemp-derived cannabinoid product that is marketed or sold as a final product or directly to an end consumer for personal or household use; (4) Any final hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code.
5ca11dce0915c0e2928.01 (C) "'Hemp' means the plant Cannabis sativa L. and any part of that plant" [...] [with a total THC concentration] "of not more than three-tenths per cent on a dry weight basis" [where total THC means] "total tetrahydrocannabinols, including tetrahydrocannabinolic acid". (C)(4) [Hemp does not include final hemp-derived cannabinoid products containing:] (a) "Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant" [...] (c) "Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols" [...]. (E) ["Hemp-derived cannabinoid product" means] "any intermediate or final product derived from hemp, other than industrial hemp" [intended for human or animal use by means] "such as inhalation, ingestion, or topical application". [Bracketed spans summarized; authenticated PDF dated 3-20-2026.]
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap